Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors
<i>Background and Objective:</i> We aim to determine the efficacy and the factors associated with the effectiveness of first-line CDK4/6i (ribociclib or palbociclib) treatment in HR-positive, HER2-negative MBC patients. <i>Materials and Methods:</i> This is a retrospective, cross-sectional, and desc...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2025-07-01
|
| Seri Bilgileri: | Medicina |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1648-9144/61/7/1279 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|